Javascript must be enabled to continue!
ANGPTL7 Exacerbates Hepatic Steatosis by promoting Inflammatory and Oxidative Stress Responses in MASLD
View through CrossRef
Abstract
The prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has been increasing. Angiopoietin - like proteins 7 (Angptl 7) plays an important role in inflammatory responses, angiogenesis and oxidative stress. However, the role of Angptl 7 on MASLD has never been investigated. Liver tissues were collected from MASLD patients (MASLD group) and normal liver tissue were chose as controls(CON). The protein expressions of Angptl 7, STAT3, iNOS, and COX-2 were detected by immunohistochemical staining. HepG2 cells were treated by OA/PA medium, lipid levels were assessed by oil red O staining. Then HepG2 cells were divided into pcDNA3.1(+) (CON), Angptl 7 overexpression (Angptl 7 OE), and Angptl 7 OE with STAT3 knockdown (Angptl 7 OE + si-STAT3) groups, while IL-6, TNF-α, ROS, MDA, SOD, and GSH levels were measured using kits. Angptl 7, STAT3, iNOS, and COX-2 expression was evaluated by RT-PCR and western blot. Compared to CON group, expressions of Angptl 7, STAT3, iNOS, and COX-2 in liver tissue were significantly increased in MASLD patients(P < 0.05). In vitro, compared to CON group, the Angptl 7 overexpression led to increased cellular ROS, MDA, IL-6, and TNF-α levels, and increased expressions of STAT3, iNOS, and COX-2 could be alleviated by STAT3 knockdown (P < 0.05). Angptl 7 participated in the pathogenesis of MASLD by increasing oxidative stress and inflammation via targeting STAT3, which might be a potential therapeutic target for MASLD therapy.
Springer Science and Business Media LLC
Title: ANGPTL7 Exacerbates Hepatic Steatosis by promoting Inflammatory and Oxidative Stress Responses in MASLD
Description:
Abstract
The prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has been increasing.
Angiopoietin - like proteins 7 (Angptl 7) plays an important role in inflammatory responses, angiogenesis and oxidative stress.
However, the role of Angptl 7 on MASLD has never been investigated.
Liver tissues were collected from MASLD patients (MASLD group) and normal liver tissue were chose as controls(CON).
The protein expressions of Angptl 7, STAT3, iNOS, and COX-2 were detected by immunohistochemical staining.
HepG2 cells were treated by OA/PA medium, lipid levels were assessed by oil red O staining.
Then HepG2 cells were divided into pcDNA3.
1(+) (CON), Angptl 7 overexpression (Angptl 7 OE), and Angptl 7 OE with STAT3 knockdown (Angptl 7 OE + si-STAT3) groups, while IL-6, TNF-α, ROS, MDA, SOD, and GSH levels were measured using kits.
Angptl 7, STAT3, iNOS, and COX-2 expression was evaluated by RT-PCR and western blot.
Compared to CON group, expressions of Angptl 7, STAT3, iNOS, and COX-2 in liver tissue were significantly increased in MASLD patients(P < 0.
05).
In vitro, compared to CON group, the Angptl 7 overexpression led to increased cellular ROS, MDA, IL-6, and TNF-α levels, and increased expressions of STAT3, iNOS, and COX-2 could be alleviated by STAT3 knockdown (P < 0.
05).
Angptl 7 participated in the pathogenesis of MASLD by increasing oxidative stress and inflammation via targeting STAT3, which might be a potential therapeutic target for MASLD therapy.
Related Results
The CRP-to-Uric Acid Index (CURI): A Novel Inflammatory–Metabolic Index to Enhance Noninvasive Screening for MASLD and Liver Fibrosis
The CRP-to-Uric Acid Index (CURI): A Novel Inflammatory–Metabolic Index to Enhance Noninvasive Screening for MASLD and Liver Fibrosis
Abstract
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) and significant liver fibrosis (SLF) require noninva...
Abstract LB177: Visualization and targeting of CD133+ cancer stem cells in MASLD-related hepatocellular carcinoma
Abstract LB177: Visualization and targeting of CD133+ cancer stem cells in MASLD-related hepatocellular carcinoma
Abstract
Metabolic dysfunction-associated steatotic liver disease related hepatocellular carcinoma (MASLD-HCC) is an emerging malignancy. However, the identity and f...
Beyond BMI: revealing metabolic risk in lean MASLD
Beyond BMI: revealing metabolic risk in lean MASLD
While Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is normally associated with obesity, increasing evidence points to a substantial disease burden in individual...
Correlation Between COVID-19 Severity, Body Mass Index and Hepatic Steatosis: A Retrograde Cohort Study
Correlation Between COVID-19 Severity, Body Mass Index and Hepatic Steatosis: A Retrograde Cohort Study
Abstract
Background Obesity and fatty liver steatosis are already considered metabolic risk factors that may aggravate the severity of COVID-19. This study aims to investig...
Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
Objective
Chemerin and adiponectin are adipokines assumed to be involved in the development of metabolic syndrome-related phenotypes like hepatic steatosis. We aimed to evaluate th...
210-OR: RNA Binding Protein YTHDC1 Critically Regulates Liver Metabolism and Homeostasis
210-OR: RNA Binding Protein YTHDC1 Critically Regulates Liver Metabolism and Homeostasis
Introduction and Objective: RNA N6-methyladenosine (m6A) modification emerges to pivotally regulate cell proliferation, differentiation, and functions. The METTL3/METTL14 complex i...
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis
AbstractAimRecently, a new technique using attenuation imaging (ATI) was developed to diagnose hepatic steatosis. The aim of this study was to investigate whether ATI for the evalu...
Genetic Risk of MASLD in Mongolians: Role of PNPLA3 and FTO SNPs
Genetic Risk of MASLD in Mongolians: Role of PNPLA3 and FTO SNPs
Background: This study aimed to determine the association between PNPLA3 rs738409, rs2896019, and FTO rs9939609, rs17817449 single-nucleotide polymorphisms and the risk of metaboli...

